I nvestment firm Bain Capital said on Friday that it has signed an agreement to acquire Mitsubishi Tanabe Pharma from ...

Bain Capital is in talks to acquire Mitsubishi Chemical Group’s pharmaceutical business in a potential multibillion-dollar deal, a person familiar with the matter said, a transaction that could ...

Mitsubishi Tanabe Pharma and Hitachi have become the latest companies attempting to use artificial intelligence (AI) to more efficiently develop drugs. The aim of the collaboration is to use ...

Bain Capital’s buyout of Mitsubishi Tanabe Pharma brings a company with a drug portfolio and pipeline in areas such as immunology, central nervous system disorders, and metabolic disease.

JERSEY CITY, N.J., April 3, 2025 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) announced 11 presentations will be shared at the American Academy of Neurology (AAN) 2025 Annual ...

US investment group Bain Capital has agreed to buy Mitsubishi Tanabe Pharma for JPY 510 billion (around $3.4 billion), setting up one of the largest private equity buyouts in Japan's healthcare ...

Japanese pharmaceutical giant Mitsubishi Tanabe Pharma Corp. announced that a COVID-19 vaccine derived from a type of tobacco plant and developed by Medicago Inc., the Osaka-based company’s ...

"These findings help build upon our understanding of edaravone's potential effects in ALS," said Gustavo A. Suarez Zambrano, M.D., Vice President of Medical Affairs at MTPA. "By modulating TDP-43 ...

Mitsubishi Tanabe Pharma Corporation isn’t backing away from the complex field of gene therapies — it’s investing in new cutting-edge projects on critical limb ischaemia and haemophilia B ...